Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00408200 · ClinicalTrials.gov registry record · NA
A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT00408200: Completed NA study, sponsored by University of Pennsylvania.
NCT00408200 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00408200, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the overall effectiveness of anti-arrhythmic medicines (to control heart rhythm) prescribed after an ablation procedure for atrial fibrillation.
Interventions
- DRUG propafenone; flecainide; sotalol; dofetilide
- DEVICE Radiofrequency catheter ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2006-11 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00408200
The ClinicalTrials.gov registry entry for NCT00408200 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which propafenone; flecainide; sotalol; dofetilide is the first listed.
NCT00408200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00408200 about?
NCT00408200 is a clinical study titled "A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation". The purpose of this study is to examine the overall effectiveness of anti-arrhythmic medicines (to control heart rhythm) prescribed after an ablation procedure for atrial fibrillation.
What is the current status of trial NCT00408200?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2006-11. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00408200?
The interventions under investigation include: propafenone; flecainide; sotalol; dofetilide (DRUG), Radiofrequency catheter ablation (DEVICE).
Who is sponsoring clinical trial NCT00408200?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.